{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T21:33:11Z","timestamp":1792359191144,"version":"4.4.0"},"reference-count":243,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Heart failure (HF) is a clinical syndrome with high incidence and prevalence and high morbidity and death rate, even in the short term, representing a serious public health issue, mainly in older people. It is a growing cause for hospital admission in this age group, being frequently associated with several comorbidities, further aggravating the disease\u2019s course. Moreover, older HF patients are usually affected by clinical conditions, like frailty, malnutrition, and cachexia, which significantly impact the overall management of HF and need to be properly identified and treated. Diagnosing and managing HF in older patients may be very complicated and challenging. Although specific data on treatment of both acute and chronic HF in older subjects are limited and mainly extrapolated from large-scale clinical trials, the standard pharmacological management may be considered well-tolerated and generally safe. In any case, a personalized and tailored approach is mandatory and is based on severity of comorbidities, overall status, and prognosis, above all in frailer and more comorbid subjects, due to the higher rate of drug interactions, side effects, and therapy discontinuation in this population. In this scenario, palliative care has become a fundamental part of HF management in the elderly in order to improve their care and the quality of life. Moreover, an increasing number of promising pharmacological options deserve further investigation in order to support clinicians in optimizing management of comorbid and frailer patients. In this work, we provide detailed and updated insight into clinical, therapeutic, and prognostic features of both acute and chronic HF in the older population.<\/jats:p>","DOI":"10.3390\/jcm14061982","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T13:07:51Z","timestamp":1741957671000},"page":"1982","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Heart Failure in Older Patients: An Update"],"prefix":"10.3390","volume":"14","author":[{"given":"Massimo","family":"Montalto","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d, IRCCS, 00168 Rome, Italy"},{"name":"Department of Geriatrics, Orthopedics and Rheumatology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"D\u2019Ignazio","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Orthopedics and Rheumatology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Camilli","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Orthopedics and Rheumatology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvino","family":"Di Francesco","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Orthopedics and Rheumatology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fedele","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Orthopedics and Rheumatology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Landi","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d, IRCCS, 00168 Rome, Italy"},{"name":"Department of Geriatrics, Orthopedics and Rheumatology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-7202","authenticated-orcid":false,"given":"Antonella","family":"Gallo","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d, IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"44","author":"Mcdonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/heartjnl-2022-322117","article-title":"Cardiogeriatrics: The Current State of the Art","volume":"110","author":"Gaur","year":"2024","journal-title":"Heart"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The Epidemiology of Heart Failure: The Framingham Study","volume":"22","author":"Ho","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","first-page":"115","article-title":"Heart Failure in the Elderly","volume":"13","author":"Alfonso","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12551-017-0255-9","article-title":"Cardiac Aging and Heart Disease in Humans","volume":"9","author":"Steenman","year":"2017","journal-title":"Biophys. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sanada, F., Taniyama, Y., Muratsu, J., Otsu, R., Shimizu, H., Rakugi, H., and Morishita, R. (2018). Source of Chronic Inflammation in Aging. Front. Cardiovasc. Med., 5.","DOI":"10.3389\/fcvm.2018.00012"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/eurheartj\/ehx343","article-title":"Cardiomyocyte Renewal in the Human Heart: Insights from the Fall-Out","volume":"38","author":"Sadek","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"NHFA CSANZ Heart Failure Guidelines Working Group, Atherton, J.J., Sindone, A., De Pasquale, C.G., Driscoll, A., MacDonald, P.S., Hopper, I., Kistler, P.M., Briffa, T., and Wong, J. (2018). National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018. Heart Lung Circ., 27, 1123\u20131208.","DOI":"10.1016\/j.hlc.2018.06.1042"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","article-title":"Sex Differences in Cardiovascular Pathophysiology","volume":"138","author":"Beale","year":"2018","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sickinghe, A.A., Korporaal, S.J.A., den Ruijter, H.M., and Kessler, E.L. (2019). Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00442"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pcad.2006.08.011","article-title":"Role of Gender in Heart Failure with Normal Left Ventricular Ejection Fraction","volume":"49","author":"Brokat","year":"2007","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1253\/circj.CJ-20-0947","article-title":"Clinical Characteristics and Outcomes of Hospitalized Patients With Heart Failure From the Large-Scale Japanese Registry Of Acute Decompensated Heart Failure (JROADHF)","volume":"85","author":"Ide","year":"2021","journal-title":"Circ. J."},{"key":"ref_14","unstructured":"(2025, February 14). Acute Heart Failure in Elderly Patients: Worse Outcomes and Differential Utility of Standard Prognostic Variables. Insights from the PROTECT Trial\u2014Metra\u20142015\u2014European Journal of Heart Failure\u2014Wiley Online Library. Available online: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ejhf.207."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.healun.2010.08.007","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Twenty-Seventh Official Adult Heart Transplant Report\u20142010","volume":"29","author":"Stehlik","year":"2010","journal-title":"J. Heart Lung Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejim.2015.08.015","article-title":"Clinical Profile, Management, and Mortality in Very-Elderly Patients Hospitalized with Acute Decompensated Heart Failure: An Analysis from the ATTEND Registry","volume":"27","author":"Mizuno","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.repc.2015.02.002","article-title":"Clinical Characteristics and Prognosis of Heart Failure in Elderly Patients","volume":"34","year":"2015","journal-title":"Rev. Port. De Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sung, S.-H., Wang, T.-J., Cheng, H.-M., Yu, W.-C., Guo, C.-Y., Chiang, C.-E., and Chen, C.-H. (2018). Clinical Characteristics and Outcomes in the Very Elderly Patients Hospitalized for Acute Heart Failure: Importance of Pharmacologic Guideline Adherence. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-32684-9"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.ajem.2016.08.015","article-title":"Characteristics and Outcomes for Acute Heart Failure in Elderly Patients Presenting to the ED","volume":"34","author":"Claret","year":"2016","journal-title":"Am. J. Emerg. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cardfail.2014.12.012","article-title":"Acute Heart Failure in the Elderly: Differences in Clinical Characteristics, Outcomes, and Prognostic Factors in the VERITAS Study","volume":"21","author":"Metra","year":"2015","journal-title":"J. Card. Fail."},{"key":"ref_21","unstructured":"(2025, February 14). Clinical Characteristics and Major Comorbidities in Heart Failure Patients More than 85 Years of Age Compared with Younger Age Groups\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/21896536\/."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: Developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) with the Special Contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_23","unstructured":"(2025, February 14). Recommendations on Pre-Hospital & Early Hospital Management of Acute Heart Failure: A Consensus Paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/25999021\/."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jacc.2008.04.028","article-title":"Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure: Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"52","author":"Abraham","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/clc.22345","article-title":"FRAIL-HF, a Study to Evaluate the Clinical Complexity of Heart Failure in Nondependent Older Patients: Rationale, Methods and Baseline Characteristics","volume":"37","author":"Ortiz","year":"2014","journal-title":"Clin. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jppr.1796","article-title":"Management of Heart Failure in Older People","volume":"52","author":"Warner","year":"2022","journal-title":"J. Pharm. Pract. Res."},{"key":"ref_27","unstructured":"(2025, February 14). Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta-Analysis\u2014PMC, Available online: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6405567\/."},{"key":"ref_28","first-page":"149","article-title":"Impact of Geriatric Assessment Variables on 30-Day Mortality among Older Patients with Acute Heart Failure","volume":"30","year":"2018","journal-title":"Emergencias"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e029458","DOI":"10.1161\/JAHA.122.029458","article-title":"Bidirectional Association Between Frailty and Cardiac Structure and Function: The Atherosclerosis Risk in Communities Study","volume":"12","author":"Ramonfaur","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10741-016-9540-0","article-title":"Review of Nutritional Screening and Assessment Tools and Clinical Outcomes in Heart Failure","volume":"21","author":"Lin","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/ehf2.12388","article-title":"Muscle Wasting and Sarcopenia in Heart Failure: A Brief Overview of the Current Literature","volume":"5","year":"2018","journal-title":"ESC Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1017\/S0029665115002438","article-title":"The Wasting Continuum in Heart Failure: From Sarcopenia to Cachexia","volume":"74","year":"2015","journal-title":"Proc. Nutr. Soc."},{"key":"ref_33","first-page":"615","article-title":"Sarcopenia in Heart Failure: Mechanisms and Therapeutic Strategies","volume":"13","author":"Collamati","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Curcio, F., Testa, G., Liguori, I., Papillo, M., Flocco, V., Panicara, V., Galizia, G., Della-Morte, D., Gargiulo, G., and Cacciatore, F. (2020). Sarcopenia and Heart Failure. Nutrients, 12.","DOI":"10.3390\/nu12010211"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardfail.2017.04.007","article-title":"Cognitive Impairment and Heart Failure: Systematic Review and Meta-Analysis","volume":"23","author":"Cannon","year":"2017","journal-title":"J. Card. Fail."},{"key":"ref_36","unstructured":"(2025, March 03). HFpEF Is the Substrate for Stroke in Obesity and Diabetes Independent of Atrial Fibrillation\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/31706838\/."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Badoer, E. (2022). New Insights Into the Role of Inflammation in the Brain in Heart Failure. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.837723"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","article-title":"A\u03b2 Amyloid Pathology Affects the Hearts of Patients with Alzheimer\u2019s Disease: Mind the Heart","volume":"68","author":"Troncone","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.recesp.2015.05.009","article-title":"Multidisciplinary Approach for Patients Hospitalized With Heart Failure","volume":"68","author":"Frankenstein","year":"2015","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ageing\/31.1.29","article-title":"Heart Failure in Older People: Causes, Diagnosis and Treatment","volume":"31","author":"Abdelhafiz","year":"2002","journal-title":"Age Ageing"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2013.06.022","article-title":"Heart Failure in the Young","volume":"62","author":"Voors","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.hrtlng.2021.05.005","article-title":"Older and Younger Patients\u2019 Perceptions, Evaluations, and Responses to Worsening Heart Failure Symptoms","volume":"50","author":"Lin","year":"2021","journal-title":"Heart Lung J. Cardiopulm. Acute Care"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-Terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ahj.2017.07.002","article-title":"Rationale and Design of the ICON-RELOADED Study: International Collaborative of N-Terminal pro-B-Type Natriuretic Peptide Re-Evaluation of Acute Diagnostic Cut-Offs in the Emergency Department","volume":"192","author":"Gaggin","year":"2017","journal-title":"Am. Heart J."},{"key":"ref_45","first-page":"002","article-title":"Assessment of the Diagnostic Value of NT-proBNP in Heart Failure with Preserved Ejection Fraction","volume":"31","author":"Birrell","year":"2024","journal-title":"Br. J. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1002\/ehf2.14894","article-title":"Setting the Optimal Threshold of NT-proBNP and BNP for the Diagnosis of Heart Failure in Patients over 75 Years","volume":"11","author":"Berthelot","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.clinbiochem.2014.04.010","article-title":"Importance of Bnp Changes during the Follow-up in Elderly Outpatients with Heart Failure","volume":"47","author":"Medina","year":"2014","journal-title":"Clin. Biochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/eurheartj\/ehu090","article-title":"Effect of B-Type Natriuretic Peptide-Guided Treatment of Chronic Heart Failure on Total Mortality and Hospitalization: An Individual Patient Meta-Analysis","volume":"35","author":"Troughton","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of Natriuretic Peptide\u2013Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial","volume":"318","author":"Felker","year":"2017","journal-title":"JAMA"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Marinescu, M., Oprea, V.D., Nechita, A., Tutunaru, D., Nechita, L.-C., and Romila, A. (2023). The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients. Diagnostics, 13.","DOI":"10.3390\/diagnostics13091512"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"64B","DOI":"10.1016\/j.jacc.2015.06.1267","article-title":"ST2 and Patient Prognosis in Chronic Heart Failure","volume":"115","author":"Zhang","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/14017431.2019.1583363","article-title":"ST2 in Heart Failure with Preserved and Reduced Ejection Fraction","volume":"53","author":"Najjar","year":"2019","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(21)03014-X","article-title":"The Prognostic Role of Soluble Suppression of Tumorigenicity 2 (Sst2) among Older Adults: Atherosclerosis Risk in Communities (Aric) Study","volume":"77","author":"Agha","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e003188","DOI":"10.1161\/JAHA.115.003188","article-title":"Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population","volume":"5","author":"Parikh","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MEJ.0000000000001053","article-title":"Acute Heart Failure in Elderly Patients Admitted to the Emergency Department with Acute Dyspnea: A Multimarker Approach Diagnostic Study","volume":"30","author":"Taheri","year":"2023","journal-title":"Eur. J. Emerg. Med."},{"key":"ref_56","unstructured":"(2025, February 14). Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/27422899\/."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/ehjci\/jew081","article-title":"Reviewer panel: EACVI Appropriateness Criteria for the Use of Cardiovascular Imaging in Heart Failure Derived from European National Imaging Societies Voting","volume":"17","author":"Garbi","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_58","unstructured":"Lancellotti (2025, February 14). Manuale di Ecocardiografia della EACVI. Available online: https:\/\/www.libreriaragni.it\/ecg\/2607-lancellotti-manuale-di-ecocardiografia-della-eacvi-9788816003675.html."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/cpf.12114","article-title":"Impact of Left Ventricular Geometry on Long-Term Survival in Elderly Men and Women","volume":"34","author":"Selmeryd","year":"2014","journal-title":"Clin. Physiol. Funct. Imaging"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Olsen, F.J., Diederichsen, S.Z., J\u00f8rgensen, P.G., Jensen, M.T., Dahl, A., Landler, N.E., Graff, C., Brandes, A., Krieger, D., and Haugan, K. (2022). Potential Role of Conventional and Speckle-Tracking Echocardiography in the Screening of Structural and Functional Cardiac Abnormalities in Elderly Individuals: Baseline Echocardiographic Findings from the LOOP Study. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0269475"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamacardio.2018.2454","article-title":"Right Ventricular Function, Right Ventricular-Pulmonary Artery Coupling, and Heart Failure Risk in 4 US Communities: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"3","author":"Nochioka","year":"2018","journal-title":"JAMA Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2603842","DOI":"10.1155\/2021\/2603842","article-title":"Deep-Learning-Based Color Doppler Ultrasound Image Feature in the Diagnosis of Elderly Patients with Chronic Heart Failure Complicated with Sarcopenia","volume":"2021","author":"Bian","year":"2021","journal-title":"J. Healthc. Eng."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00508-016-1138-y","article-title":"Heart Failure Management in the Elderly\u2014A Public Health Challenge","volume":"128","author":"Cvetinovic","year":"2016","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1001\/archinte.162.15.1682","article-title":"Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials","volume":"162","author":"Heiat","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/eurheartj\/ehn539","article-title":"Contemporary Management of Octogenarians Hospitalized for Heart Failure in Europe: Euro Heart Failure Survey II","volume":"30","author":"Komajda","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2165\/00002018-199615030-00005","article-title":"ACE Inhibitors and the Kidney. A Risk-Benefit Assessment","volume":"15","author":"Navis","year":"1996","journal-title":"Drug Saf."},{"key":"ref_67","unstructured":"Patel, P., Sanghavi, D.K., Morris, D.L., and Kahwaji, C.I. (2025). Angiotensin II. StatPearls, StatPearls Publishing."},{"key":"ref_68","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"The SOLVD Investigators, Yusuf, S., Pitt, B., Davis, C.E., Hood, W.B., and Cohn, J.N. (1991). Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure. N. Engl. J. Med., 325, 293\u2013302.","DOI":"10.1056\/NEJM199108013250501"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"CONSENSUS Trial Study Group (1987). Effects of Enalapril on Mortality in Severe Congestive Heart Failure. N. Engl. J. Med., 316, 1429\u20131435.","DOI":"10.1056\/NEJM198706043162301"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an Angiotensin-Converting\u2013Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","article-title":"ACCF\/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension","volume":"57","author":"Aronow","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/eurheartj\/ehn476","article-title":"CHARM Investigators Benefits and Safety of Candesartan Treatment in Heart Failure Are Independent of Age: Insights from the Candesartan in Heart Failure--Assessment of Reduction in Mortality and Morbidity Programme","volume":"29","author":"McMurray","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1016\/S1520-765X(03)90047-2","article-title":"Val-HeFT: Changing the Heart Failure Horizon","volume":"5","author":"Cohn","year":"2003","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cjca.2024.04.006","article-title":"Heart Failure With Preserved Ejection Fraction in the Elderly Population: Basic Mechanisms and Clinical Considerations","volume":"40","author":"Gharagozloo","year":"2024","journal-title":"Can. J. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"PEP-CHF Investigators The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) Study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/CIRCHEARTFAILURE.109.898916","article-title":"A Randomized Double-Blind Trial of Enalapril in Older Patients With Heart Failure and Preserved Ejection Fraction","volume":"3","author":"Kitzman","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(97)01187-2","article-title":"Randomised Trial of Losartan versus Captopril in Patients over 65 with Heart Failure (Evaluation of Losartan in the Elderly Study, ELITE)","volume":"349","author":"Pitt","year":"1997","journal-title":"Lancet"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of Losartan Compared with Captopril on Mortality in Patients with Symptomatic Heart Failure: Randomised Trial\u2014The Losartan Heart Failure Survival Study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ijcard.2015.03.428","article-title":"Does the Target Dose of Neurohormonal Blockade Matter for Outcome in Systolic Heart Failure in Octogenarians?","volume":"187","author":"Barywani","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.ajkd.2011.09.002","article-title":"Combining Angiotensin Receptor Blockers with ACE Inhibitors in Elderly Patients","volume":"59","author":"Anand","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/heartjnl-2021-319405","article-title":"Effectiveness of Angiotensin-Neprilysin Inhibitor Treatment versus Renin-Angiotensin System Blockade in Older Adults with Heart Failure in Clinical Care","volume":"107","author":"Desai","year":"2021","journal-title":"Heart"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/eurheartj\/ehv330","article-title":"Efficacy and Safety of LCZ696 (Sacubitril-Valsartan) According to Age: Insights from PARADIGM-HF","volume":"36","author":"Jhund","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Maury, E., Belmans, A., Bogaerts, K., Vancayzeele, S., and Jansen, M. (2024). Real-Life Effectiveness of Sacubitril\/Valsartan in Older Belgians with Heart Failure, Reduced Ejection Fraction and Most Severe Symptoms. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-64243-w"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.regg.2019.10.002","article-title":"Sacubitril\/Valsartan Is Useful and Safe in Elderly People with Heart Failure and Reduced Ejection Fraction. Data from a Real-Word Cohort","volume":"55","author":"Vicent","year":"2020","journal-title":"Rev. Esp. Geriatr. Gerontol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"L77","DOI":"10.1093\/eurheartj\/suaa140","article-title":"The PARAGON-HF Trial: The Sacubitril\/Valsartan in Heart Failure with Preserved Ejection Fraction","volume":"22","author":"Gronda","year":"2020","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1111\/jgs.18481","article-title":"Frailty and Uptake of Angiotensin Receptor Neprilysin Inhibitor for Heart Failure with Reduced Ejection Fraction","volume":"71","author":"Lee","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_90","unstructured":"(2025, February 14). Frailty Interferes with the Guideline-Directed Medical Therapy in Heart Failure Patients with Reduced Ejection Fraction\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/36193578\/."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coph.2016.02.005","article-title":"Mineralocorticoid Receptor Antagonists-Pharmacodynamics and Pharmacokinetic Differences","volume":"27","author":"Yang","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jchf.2019.08.017","article-title":"MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPHASIS-HF, and TOPCAT","volume":"7","author":"Ferreira","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(24)01733-1","article-title":"Mineralocorticoid Receptor Antagonists in Heart Failure: An Individual Patient Level Meta-Analysis","volume":"404","author":"Jhund","year":"2024","journal-title":"Lancet"},{"key":"ref_94","unstructured":"(2025, February 14). Aldosterone Antagonists and Outcomes in Real-World Older Patients with Heart Failure and Preserved Ejection Fraction\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/23814702\/."},{"key":"ref_95","unstructured":"(2025, February 14). Spironolactone for Heart Failure with Preserved Ejection Fraction\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/24716680\/."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1574887109666140908125402","article-title":"Mechanisms of Beta-Blockers Action in Patients with Heart Failure","volume":"9","author":"Prijic","year":"2014","journal-title":"Rev. Recent. Clin. Trials"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2021.03.035","article-title":"The Use of \u03b2-Blockers in Patients with Heart Failure and Comorbidities: Doubts, Certainties and Unsolved Issues","volume":"88","author":"Paolillo","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"ref_99","first-page":"1","article-title":"I \u03b2-bloccanti nello scompenso cardiaco cronico","volume":"1","author":"Agostoni","year":"2022","journal-title":"Clin. Pract."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"(1999). The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A Randomised Trial. Lancet, 353, 9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jama.289.6.712","article-title":"Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group Effects of Initiating Carvedilol in Patients with Severe Chronic Heart Failure: Results from the COPERNICUS Study","volume":"289","author":"Krum","year":"2003","journal-title":"JAMA"},{"key":"ref_102","unstructured":"(2025, February 14). Effect of Metoprolol CR\/XL in Chronic Heart Failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/10376614\/."},{"key":"ref_103","unstructured":"(2025, February 14). Randomized Trial to Determine the Effect of Nebivolol on Mortality and Cardiovascular Hospital Admission in Elderly Patients with Heart Failure (SENIORS)\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/15642700\/."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"i1855","DOI":"10.1136\/bmj.i1855","article-title":"Effect of Age and Sex on Efficacy and Tolerability of \u03b2 Blockers in Patients with Heart Failure with Reduced Ejection Fraction: Individual Patient Data Meta-Analysis","volume":"353","author":"Kotecha","year":"2016","journal-title":"BMJ"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-Blockers for Heart Failure with Reduced, Mid-Range, and Preserved Ejection Fraction: An Individual Patient-Level Analysis of Double-Blind Randomized Trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Ma, T., Su, Y., Song, J., and Xu, D. (2021). Treatment of Heart Failure With Mid-Range Ejection Fraction: A Summary of Current Evidence. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.653336"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijcard.2014.03.005","article-title":"Beta-Blockers in Older Patients with Heart Failure and Preserved Ejection Fraction: Class, Dosage, and Outcomes","volume":"173","author":"Patel","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","article-title":"Effects of Carvedilol on Heart Failure with Preserved Ejection Fraction: The Japanese Diastolic Heart Failure Study (J-DHF)","volume":"15","author":"Yamamoto","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"ref_109","unstructured":"(2025, February 14). Age- and Gender-Related Differences in Quality of Care and Outcomes of Patients Hospitalized with Heart Failure (from OPTIMIZE-HF)\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/19576329\/."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurjhf\/hfr020","article-title":"Titration to Target Dose of Bisoprolol vs. Carvedilol in Elderly Patients with Heart Failure: The CIBIS-ELD Trial","volume":"13","author":"Apostolovic","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"ref_111","unstructured":"(2025, February 14). Beta Blockers in Older Persons with Heart Failure: Tolerability and Impact on Quality of Life\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/12433890\/."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"154937","DOI":"10.1016\/j.metabol.2021.154937","article-title":"SGLT-2 Inhibitors as Cardio-Renal Protective Agents","volume":"127","author":"Caruso","year":"2022","journal-title":"Metabolism"},{"key":"ref_113","unstructured":"(2025, February 14). Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/36027570\/."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_115","unstructured":"(2025, February 14). Efficacy and Safety Profile of SGLT2 Inhibitors in the Elderly: How Is the Benefit\/Risk Balance?\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/36640828\/."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"The EMPA-KIDNEY Collaborative Group, Herrington, W.G., Staplin, N., Wanner, C., Green, J.B., Hauske, S.J., Emberson, J.R., Preiss, D., Judge, P., and Mayne, K.J. (2023). Empagliflozin in Patients with Chronic Kidney Disease. N. Engl. J. Med., 388, 117\u2013127.","DOI":"10.1056\/NEJMoa2204233"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.hfc.2022.03.002","article-title":"SGLT2 Inhibitors and Safety in Older Patients","volume":"18","author":"Pollack","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"ref_122","unstructured":"(2025, February 14). Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/36029465\/."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/M21-4776","article-title":"Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction: A Post Hoc Analysis of the DAPA-HF Trial","volume":"175","author":"Butt","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic Therapy for Patients with Heart Failure: JACC State-of-the-Art Review","volume":"75","author":"Felker","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","article-title":"Diuretic Therapy and Resistance in Congestive Heart Failure","volume":"96","author":"Ellison","year":"2001","journal-title":"Cardiology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchf.2014.09.003","article-title":"Decongestion Strategies and Renin-Angiotensin-Aldosterone System Activation in Acute Heart Failure","volume":"3","author":"Mentz","year":"2015","journal-title":"JACC Heart Fail."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1681\/ASN.2016111178","article-title":"Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure","volume":"28","author":"Rao","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40262-012-0029-2","article-title":"Clinical Pharmacokinetics of Drugs in Patients with Heart Failure: An Update (Part 1, Drugs Administered Intravenously)","volume":"52","author":"Ogawa","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11897-023-00617-x","article-title":"The Association Between Intra-Abdominal Pressure and Diuretic Response in Heart Failure","volume":"20","year":"2023","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e009149","DOI":"10.1161\/JAHA.118.009149","article-title":"Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis","volume":"7","author":"Houser","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-199703000-00010","article-title":"Sequential Nephron Blockade Breaks Resistance to Diuretics in Edematous States","volume":"29","author":"Knauf","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"155002","DOI":"10.1016\/j.jcrc.2024.155002","article-title":"Furosemide with Adjunctive Acetazolamide vs Furosemide Only in Critically Ill Patients: A Pilot Two-Center Randomized Controlled Trial","volume":"86","author":"Maeda","year":"2025","journal-title":"J. Crit. Care"},{"key":"ref_133","first-page":"e76697","article-title":"A Systematic Review of Baseline Characteristics of Patients With Successful Decongestion on Combination Diuretic Therapy in Acute Decompensated Heart Failure (ADHF)","volume":"16","author":"Tunuguntla","year":"2024","journal-title":"Cureus"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"EVIDra2200053","DOI":"10.1056\/EVIDra2200053","article-title":"Mechanistic Insights in Cardiorenal Syndrome","volume":"1","author":"Lo","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The Use of Diuretics in Heart Failure with Congestion\u2014A Position Statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Bahar, J., Rahman, A., Wong, G.W.Y., Sankaranarayanan, R., Ahmed, F.Z., Taylor, R., Fuat, A., Squire, I., Cleland, J.G.F., and Lip, G.Y.H. (2024). Outpatient Treatment of Decompensated Heart Failure: A Systematic Review and Study Level Meta-Analysis. ESC Heart Fail., Online ahead of print.","DOI":"10.1002\/ehf2.14841"},{"key":"ref_138","unstructured":"(2025, February 14). Efficacy and Safety of Ivabradine in Chronic Heart Failure across the Age Spectrum: Insights from the SHIFT Study\u2014Tavazzi\u20142013\u2014European Journal of Heart Failure\u2014Wiley Online Library. Available online: https:\/\/onlinelibrary.wiley.com\/doi\/10.1093\/eurjhf\/hft102."},{"key":"ref_139","unstructured":"(2025, February 14). Long-Term Treatment with Ivabradine over 12 Months in Patients with Chronic Heart Failure in Clinical Practice: Effect on Symptoms, Quality of Life and Hospitalizations\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/28408104\/."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","article-title":"Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure","volume":"371","author":"Fox","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_141","unstructured":"David, M.N.V., and Shetty, M. (2025). Digoxin. StatPearls, StatPearls Publishing."},{"key":"ref_142","unstructured":"(2025, February 14). The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/9036306\/."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0735-1097(01)01442-5","article-title":"Digitalis Investigation Group Effect of Age on Mortality, Hospitalizations and Response to Digoxin in Patients with Heart Failure: The DIG Study","volume":"38","author":"Rich","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/ejhf.1160","article-title":"Effect of Digoxin in Patients with Heart Failure and Mid-Range (Borderline) Left Ventricular Ejection Fraction","volume":"20","author":"Shen","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_145","unstructured":"(2025, February 14). Pharmacotherapy of Heart Failure in the Elderly: Adverse Events | Heart Failure Reviews. Available online: https:\/\/link.springer.com\/article\/10.1007\/s10741-011-9263-1."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart Failure With Reduced Ejection Fraction: A Review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1159\/000541393","article-title":"Efficacy of Modern Therapies for Heart Failure with Reduced Ejection Fraction in Specific Population Subgroups: A Systematic Review and Network Meta-Analysis","volume":"14","author":"Lavalle","year":"2024","journal-title":"Cardiorenal Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","article-title":"Vericiguat in Patients with Worsening Chronic Heart Failure and Preserved Ejection Fraction: Results of the SOluble Guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) Study","volume":"38","author":"Pieske","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"D278","DOI":"10.1093\/eurheartjsupp\/suad106","article-title":"ANMCO Position Paper on Vericiguat Use in Heart Failure: From Evidence to Place in Therapy","volume":"25","author":"Alonzo","year":"2023","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jama.2020.15922","article-title":"Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial","volume":"324","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/ejhf.1305","article-title":"Screening, Diagnosis and Treatment of Iron Deficiency in Chronic Heart Failure: Putting the 2016 European Society of Cardiology Heart Failure Guidelines into Clinical Practice","volume":"20","author":"McDonagh","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ejhf.467","article-title":"The Influence of Iron Deficiency on the Functioning of Skeletal Muscles: Experimental Evidence and Clinical Implications","volume":"18","author":"Stugiewicz","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00392-023-02207-2","article-title":"Efficacy and Safety of Intravenous Iron Repletion in Patients with Heart Failure: A Systematic Review and Meta-Analysis","volume":"112","author":"Abdin","year":"2023","journal-title":"Clin. Res. Cardiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous Ferric Derisomaltose in Patients with Heart Failure and Iron Deficiency in the UK (IRONMAN): An Investigator-Initiated, Prospective, Randomised, Open-Label, Blinded-Endpoint Trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"ref_157","unstructured":"(2025, March 05). Ferric Carboxymaltose for Iron Deficiency at Discharge After Acute Heart Failure: A Multicentre, Double-Blind, Randomised, Controlled Trial\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/33197395\/."},{"key":"ref_158","unstructured":"(2025, March 05). Ferric Carboxymaltose for the Treatment of Iron-Deficient Heart Failure Patients: A Systematic Review and Meta-Analysis\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/33586856\/."},{"key":"ref_159","unstructured":"(2025, March 05). Anemia Management in the Cardiorenal Patient: A Nephrological Perspective | Journal of the American Heart Association. Available online: https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.124.037363."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.kisu.2020.12.001","article-title":"Anemia of Cardiorenal Syndrome","volume":"11","author":"McCullough","year":"2021","journal-title":"Kidney Int. Suppl."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jchf.2021.04.005","article-title":"Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron Therapy","volume":"9","author":"Jhund","year":"2021","journal-title":"JACC Heart Fail."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"645.e9\u2013645.e15","DOI":"10.1016\/j.ahj.2007.07.022","article-title":"Effects of Beta-Erythropoietin Treatment on Left Ventricular Remodeling, Systolic Function, and B-Type Natriuretic Peptide Levels in Patients with the Cardiorenal Anemia Syndrome","volume":"154","author":"Palazzuoli","year":"2007","journal-title":"Am. Heart J."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"(2025, March 05). Impact of Erythropoietin Therapy on Cardiorenal Syndrome: A Systematic Review with Meta-Analysis. Available online: https:\/\/www.wjgnet.com\/1949-8462\/full\/v15\/i5\/273.htm.","DOI":"10.4330\/wjc.v15.i5.273"},{"key":"ref_164","first-page":"100","article-title":"Cardiovascular Effects of Hemoglobin Response in Patients Receiving Epoetin Alfa and Oral Iron in Heart Failure with a Preserved Ejection Fraction","volume":"11","author":"Vullaganti","year":"2014","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_165","unstructured":"(2025, February 14). Benefit of Cardiac Resynchronization in Elderly Patients: Results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) Trials\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/19152106\/."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/europace\/eus376","article-title":"Cardiac Resynchronization Therapy Improves Ejection Fraction and Cardiac Remodelling Regardless of Patients\u2019 Age","volume":"15","author":"Brambatti","year":"2013","journal-title":"Europace"},{"key":"ref_167","unstructured":"(2025, February 14). Improved Outcome with Preventive Cardiac Resynchronization Therapy in the Elderly: A MADIT-CRT Substudy\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/21831163\/."},{"key":"ref_168","unstructured":"(2025, February 14). Long-Term Outcome of Cardiac Resynchronization Therapy Patients in the Elderly\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/36800059\/."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5603\/CJ.2011.0005","article-title":"Use of Implantable Cardioverter-Defibrillators for Primary Prevention in Older Patients: A Systematic Literature Review and Meta-Analysis","volume":"18","author":"Kong","year":"2011","journal-title":"Cardiol. J."},{"key":"ref_170","first-page":"40","article-title":"I dispositivi negli anziani con scompenso cardiaco cronico","volume":"14","author":"Fumagalli","year":"2013","journal-title":"G. Ital. Cardiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"ref_172","unstructured":"Balasubramanian, S., and Chowdhury, Y.S. (2025). Isosorbide. StatPearls, StatPearls Publishing."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cardfail.2016.10.004","article-title":"Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes","volume":"22","author":"Kim","year":"2016","journal-title":"J. Card. Fail."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cardfail.2013.12.015","article-title":"Survival in Elderly Patients Supported with Continuous Flow Left Ventricular Assist Device as Bridge to Transplantation or Destination Therapy","volume":"20","author":"Rosenbaum","year":"2014","journal-title":"J. Card. Fail."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.athoracsur.2013.04.010","article-title":"Ventricular Assist Device Implant in the Elderly Is Associated with Increased, but Respectable Risk: A Multi-Institutional Study","volume":"96","author":"Atluri","year":"2013","journal-title":"Ann. Thorac. Surg."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"117897","DOI":"10.1016\/j.atherosclerosis.2024.117897","article-title":"Polypharmacy and Comorbidity of Elderly Patients with Diabetes and Heart Failure Admitted to Internal Medicine Ward","volume":"395","author":"Papakitsou","year":"2024","journal-title":"Atherosclerosis"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10741-017-9598-3","article-title":"Heart Failure in the Elderly: Ten Peculiar Management Considerations","volume":"22","author":"Bader","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","article-title":"When Drug Therapy Gets Old: Pharmacokinetics and Pharmacodynamics in the Elderly","volume":"38","author":"Turnheim","year":"2003","journal-title":"Exp. Gerontol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.acvd.2016.01.014","article-title":"Temporal Trends in Nitrate Utilization for Acute Heart Failure in Elderly Emergency Patients: A Single-Centre Observational Study","volume":"109","author":"Lemachatti","year":"2016","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.2020.19378","article-title":"Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial","volume":"324","author":"Freund","year":"2020","journal-title":"JAMA"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0002-9149(90)90823-J","article-title":"Inotropic Response to Dobutamine in Elderly Patients with Decompensated Congestive Heart Failure","volume":"65","author":"Rich","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.RES.36.2.262","article-title":"Diminished Inotropic Response of Aged Myocardium to Catecholamines","volume":"36","author":"Lakatta","year":"1975","journal-title":"Circ. Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/ejhf.2920","article-title":"Safety, Tolerability and Efficacy of up-Titration of Guideline-Directed Medical Therapies for Acute Heart Failure in Elderly Patients: A Sub-Analysis of the STRONG-HF Randomized Clinical Trial","volume":"25","author":"Arrigo","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2017.02.070","article-title":"Current Use of Guideline-Based Medical Therapy in Elderly Patients Admitted with Acute Heart Failure with Reduced Ejection Fraction and Its Impact on Event-Free Survival","volume":"235","author":"Akita","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jacc.2016.04.047","article-title":"Influence of Sacubitril\/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization","volume":"68","author":"Desai","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of Empagliflozin on Decongestion in Acute Heart Failure: The EMPULSE Trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.07.018","article-title":"Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care","volume":"66","author":"Rossello","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.hrtlng.2022.08.021","article-title":"Frailty in Elderly Patients with Acute Heart Failure Increases Readmission","volume":"57","author":"Umehara","year":"2023","journal-title":"Heart Lung"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2013.09.070","article-title":"Frailty Assessment in the Cardiovascular Care of Older Adults","volume":"63","author":"Afilalo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_191","first-page":"669","article-title":"Prediction Model of In-Hospital Mortality in Elderly Patients with Acute Heart Failure Based on Retrospective Study","volume":"14","author":"Jia","year":"2017","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1177\/0003319720941758","article-title":"A New Risk Score to Predict In-Hospital Mortality in Elderly Patients with Acute Heart Failure: On Behalf of the Journey HF-TR Study Investigators","volume":"71","author":"Sinan","year":"2020","journal-title":"Angiology"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejim.2020.05.017","article-title":"Clinical Profile and 1-Year Clinical Outcomes of Super Elderly Patients Admitted with Acute Heart Failure","volume":"81","author":"Lorenzo","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_194","unstructured":"(2025, February 14). Mode of Death in Elderly and Super-Elderly Patients with Acute Heart Failure: Insights from Japanese Heart Failure Registry\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/33963771\/."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejim.2014.04.002","article-title":"Characteristics of Acute Heart Failure in Very Elderly Patients\u2014EVE Study (EAHFE Very Elderly)","volume":"25","author":"Jacob","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s40520-019-01363-8","article-title":"Differential Characteristics of Acute Heart Failure in Very Elderly Patients: The Prospective RICA Study","volume":"32","author":"Franco","year":"2020","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_197","unstructured":"(2025, February 14). Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/34196911\/."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Irabor, B., McMillan, J.M., and Fine, N.M. (2022). Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.863179"},{"key":"ref_199","unstructured":"(2025, February 14). Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/31171094\/."},{"key":"ref_200","unstructured":"(2025, February 14). 2023 ESC Guidelines for the Management of Cardiomyopathies\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/37622657\/."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling Transthyretin Cardiac Amyloidosis and Its Predictors among Elderly Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement","volume":"38","author":"Narotsky","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_202","unstructured":"(2025, February 14). Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/33181246\/."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cjca.2019.11.039","article-title":"Arrhythmias in Cardiac Amyloidosis: Challenges in Risk Stratification and Treatment","volume":"36","author":"Cheung","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_207","unstructured":"(2025, February 14). Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/29972757\/."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.cjca.2021.01.015","article-title":"Establishing a Cardiac Amyloidosis Clinic: A Practical Primer for Cardiologists","volume":"37","author":"Davis","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"ref_209","unstructured":"(2025, February 14). Palliative Care. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/palliative-care."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/ejhf.2981","article-title":"Palliative Care in Heart Failure Guidelines: A Comparison of the 2021 ESC and the 2022 AHA\/ACC\/HFSA Guidelines on Heart Failure","volume":"25","author":"Blum","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"ref_211","unstructured":"(2025, February 14). Heart Disease and Stroke Statistics-2023 Update: A Report from the American Heart Association\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/36695182\/."},{"key":"ref_212","unstructured":"(2025, February 14). Inpatient Palliative Care for Patients with Acute Heart Failure: Outcomes from a Randomized Trial\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/25479182\/."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacc.2017.05.030","article-title":"The Palliative Care in Heart Failure (PAL-HF) Randomized, Controlled Clinical Trial","volume":"70","author":"Rogers","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamainternmed.2017.8667","article-title":"Effect of a Collaborative Care Intervention vs Usual Care on Health Status of Patients With Chronic Heart Failure: The CASA Randomized Clinical Trial","volume":"178","author":"Bekelman","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"ref_215","unstructured":"(2025, February 14). Effect of an Early Palliative Care Telehealth Intervention vs Usual Care on Patients with Heart Failure: The ENABLE CHF-PC Randomized Clinical Trial\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/32730613\/."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/jpm.2013.0658","article-title":"Palliative Care Referral among Patients Hospitalized with Advanced Heart Failure","volume":"17","author":"Greener","year":"2014","journal-title":"J. Palliat. Med."},{"key":"ref_217","unstructured":"(2025, February 14). Trends in Palliative Care Use in Veterans With Severe Heart Failure Using a Large National Cohort\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/27434266\/."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.rmed.2008.01.007","article-title":"Health Care Utilization of Patients with Chronic Obstructive Pulmonary Disease and Lung Cancer in the Last 12 Months of Life","volume":"102","author":"Goodridge","year":"2008","journal-title":"Respir. Med."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1200\/JCO.2015.61.6458","article-title":"Racial\/Ethnic Differences in Inpatient Palliative Care Consultation for Patients with Advanced Cancer","volume":"33","author":"Sharma","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_220","unstructured":"(2025, February 14). The Right Time for Palliative Care in Heart Failure: A Review of Critical Moments for Palliative Care Intervention\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/31611151\/."},{"key":"ref_221","unstructured":"(2025, February 14). What Tools Are Available to Identify Patients with Palliative Care Needs in Primary Care: A Systematic Literature Review and Survey of European Practice\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/24950525\/."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ejhf.1994","article-title":"Integration of a Palliative Approach into Heart Failure Care: A European Society of Cardiology Heart Failure Association Position Paper","volume":"22","author":"Hill","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_223","first-page":"CD011008","article-title":"Opioids for the Palliation of Refractory Breathlessness in Adults with Advanced Disease and Terminal Illness","volume":"3","author":"Barnes","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pcad.2016.01.002","article-title":"Palliative Care in Heart Failure","volume":"58","author":"Ghashghaei","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.hfc.2019.12.006","article-title":"Palliative Care in Patients with Advanced Heart Failure","volume":"16","author":"Kida","year":"2020","journal-title":"Heart Fail. Clin."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2010.01.006","article-title":"Danish Heart Failure Clinics Network High Mortality among Heart Failure Patients Treated with Antidepressants","volume":"146","author":"Veien","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tcm.2018.02.008","article-title":"Palliative Care in Heart Failure","volume":"28","author":"Wiskar","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.medcli.2024.04.029","article-title":"Deactivation of Cardiac Implantable Electronic Devices in Palliative Patients: When and How","volume":"163","author":"Oliveira","year":"2024","journal-title":"Med. Clin."},{"key":"ref_229","unstructured":"(2025, February 14). Palliative Care for People Living with Heart Failure: European Association for Palliative Care Task Force Expert Position Statement\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/31386104\/."},{"key":"ref_230","unstructured":"(2025, February 14). The Role of Palliative Care for Patients with Left Ventricular Assist Devices: A Narrative Review\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/38462933\/."},{"key":"ref_231","unstructured":"(2025, February 14). End-of-Life Decision Making and Implementation in Recipients of a Destination Left Ventricular Assist Device\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/20817564\/."},{"key":"ref_232","unstructured":"(2025, February 14). Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice\/Palliative Medicine Clinicians\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/27932271\/."},{"key":"ref_233","unstructured":"(2025, February 14). End of Life for Patients with Left Ventricular Assist Devices: Insights from INTERMACS\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/30642799\/."},{"key":"ref_234","unstructured":"(2025, February 14). EHRA Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices in Patients Nearing End of Life or Requesting Withdrawal of Therapy\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/20675674\/."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, Mortality, and Kidney Outcomes with GLP-1 Receptor Agonists in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus Placebo in People with Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF DM Randomised Trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacc.2024.08.016","article-title":"Effects of GLP-1 Receptor Agonists on Heart Failure Outcomes: The FLOW of Evidence","volume":"84","author":"Kittipibul","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_238","first-page":"121","article-title":"Position paper ANMCO\u2014Stati Generali ANMCO 2023: Verso una moderna Cardiologia Territoriale","volume":"25","author":"Zuin","year":"2024","journal-title":"G. Ital. Cardiol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.hfc.2020.06.002","article-title":"Empowering People Living with Heart Failure","volume":"16","author":"Wohlfahrt","year":"2020","journal-title":"Heart Fail. Clin."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"177","DOI":"10.14744\/AnatolJCardiol.2023.3873","article-title":"Role of Telemedicine Intervention in the Treatment of Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis","volume":"28","author":"Wang","year":"2024","journal-title":"Anatol. J. Cardiol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4330\/wjc.v14.i12.640","article-title":"Telemonitoring in Heart Failure Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"14","author":"Umeh","year":"2022","journal-title":"World J. Cardiol."},{"key":"ref_242","unstructured":"(2025, March 06). CardioMEMS: Where We Are and Where Can We Go?\u2014Pour-Ghaz\u2014Annals of Translational Medicine. Available online: https:\/\/atm.amegroups.org\/article\/view\/28018\/25381."},{"key":"ref_243","first-page":"107","article-title":"Continuit\u00e0 assistenziale nei pazienti con scompenso cardiaco: Ruolo delle tecnologie wireless per la telemedicina. Il progetto ICAROS","volume":"8","author":"Villani","year":"2007","journal-title":"G. Ital. Cardiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/6\/1982\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:53:55Z","timestamp":1760028835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/6\/1982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":243,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["jcm14061982"],"URL":"https:\/\/doi.org\/10.3390\/jcm14061982","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}